Characterizing prostate cancer and watchful waiting (PIONEER)
=============
<h2>PLEASE NOTE: All results are preliminary and subject to change</h2>

<hr class="w-100" style="border-top: black 1px solid;">

<h3>Terms of Use:</h3>
<p>These results are being shared as part of OHDSI's open science community efforts to characterize disease natural history of COVID-19, for the purposes of enabling collaborative research within the community.  Synthesis of the results and interpretation of the findings is underway and manuscripts are being prepared.  All manuscripts must be reviewed and approved by all co-authors and data partner contributors prior to submission.  Until final publication, all results are to be considered preliminary and subject to change, and may only be used under the terms of use of the respective data partner contributors.</p>

**Objectives:**<br>
1) Describe the baseline demographic, clinical characteristics, treatments and outcomes of interest among individuals diagnosed with prostate cancer and stratified by age and specific comorbidities;<br>

**Resources:**<br>


**Cohort Diagnostics:**<br>
